Bristol Myers Squibb (BMY) valuation history
Within its usual range
As of
BMY's EV/EBITDA of 9.4x is lower than 60% of its available weekly readings from the last five years.
Share EV/EBITDA history
Chart by stockresearch.app. Reuse with credit under CC BY 4.0.
EV/EBITDA at year-end
Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.
| Reading date | EV/EBITDA | 5-year rank |
|---|---|---|
| 9.5× | 43% | |
| 30.9× | 94% | |
| 6.9× | 3% | |
| 9.6× | 10% | |
| 21.2× | 86% | |
| 12.1× | 16% | |
| 12.3× | 16% | |
| 12.9× | 0% | |
| 15.9× | 15% | |
| 20.2× | 25% |
Loading related research…
About this history
- What is BMY's current EV/EBITDA?
- BMY's EV/EBITDA of 9.4x is lower than 60% of its available weekly readings from the last five years.
- What is BMY's five-year median EV/EBITDA?
- The median, or middle weekly reading, is 9.7× over the last five years. Available history contains 860 weekly observations from May 3, 2010 to Oct 19, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.